Invenomic Capital Management’s Sensus Healthcare SRTS Stock Holding History

Invenomic Capital Management’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-273,342	Closed	-$985K	–	165
2021 Q3	$985K	Buy	273,342 +5,442	+2%	+$19.9K	0.32%	88
2021 Q2	$1.03M	Sell	267,900 -20,302	-7%	-$76.2K	0.25%	80
2021 Q1	$1.1M	Sell	288,202 -15,564	-5%	-$63.9K	0.25%	72
2020 Q4	$1.17M	Buy	303,766 +86,139	+40%	+$263K	0.3%	68
2020 Q3	$548K	Buy	217,627 +25,485	+13%	+$71.8K	0.3%	88
2020 Q2	$593K	Buy	192,142 +51,007	+36%	+$133K	0.44%	72
2020 Q1	$353K	Sell	141,135 -5,176	-4%	-$19.3K	0.29%	90
2019 Q4	$518K	Buy	+146,311	New	+$662K	0.21%	95

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invenomic Capital Management's SRTS Position: Q4 2021 in Review

Invenomic Capital Management sold out of Sensus Healthcare (SRTS) in Q4 2021, closing a stake of 273,342 shares — an estimated $985K sold.

Invenomic Capital Management first reported a position in SRTS in Q4 2019 and held it in 8 quarters. The position peaked at $1.17M in Q4 2020. 41 funds tracked by Wall St. Rank hold SRTS as of Q4 2021.

Invenomic Capital Management reported no remaining Sensus Healthcare position as of Q4 2021 after selling out during the quarter.
Invenomic Capital Management sold 273,342 Sensus Healthcare shares in Q4 2021, an estimated $985K.
Invenomic Capital Management first reported a position in Sensus Healthcare in Q4 2019 and held it in 8 quarters.
Invenomic Capital Management's Sensus Healthcare position peaked at $1.17M in Q4 2020.
41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2021.

Based on Invenomic Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.